ASPI ASP Isotopes Inc. Common Stock
Trend channel, buy level and 3-month target. Information only, not financial advice.
Inside the channel · 9-month channel falling
Price is between the lines.
- 9-month channel
- US$1.75 – US$2.97 · falling, −68% a year
- Price in channel
- 15% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$2.97
- Turns bearish below
- US$1.75
What broke this trend
- The fall
- -86% from US$14.0814 Oct 2025 → 23 Oct 2026
- Whose problem it was
- This company0 of 3 Chemicals - Specialty peers fell with it
- Does it resolve?
- Unsettled too close to a coin toss on the record to call
- Regained so far
- 1%of what it lost
- What the record says
- 37% of 253 comparable falls came back, typically in 180 days measured across every stock we hold history for, its peer group being too small
Fell -86% (14 Oct 2025 → 23 Oct 2026); regained 1% so far; company-specific.
Reported at the time: ASP Isotopes Announces Update Featuring Its Largest-Ever Supply Agreement For Enriched Silicon-28 And Acquisition Of A U.S. Radiopharmacy To Expand And Complement Its South African Subsidiary, Pet Labs Pharmaceuticals — 13 Oct 2025
Price history, with the path projected 3 months forward
Updated 5:17 PM ET (6 h ago)
- Daily close
- Upper trend line (9 months)
- Lower trend line (9 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy now
US$1.93
last close · 2 Nov 2026
Our target
US$2.95
by 28 Dec 2026
Projected move
53.0%
gross, before costs
Last close is our buy.
Target: ASPI's usual move size.
This move size: reached in 77% of 13 past stretches, typically in 19 days. (0.53% per day)
5 settled calls · 4 reached target (80%) · average best move 31.2%. See the full record.
- Upper line touches
- 2
- Lower line touches
- 2
- Fit confidence
- 42%
- Fitted
- 2 Nov 2026
Company information
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Paul Elliot Mann
- Employees
- 271
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$297.42M
- Enterprise value
- —
- Beta
- 3.70
- Avg volume
- 4.18M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 1.89-10.14
- Exchange
- NASDAQ
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.